Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ERJ Open Research is Scopus-indexed (Q1, CiteScore 6), WoS SCIE, DOAJ. Published by European Respiratory Society.
Checked against the index lists dated .
ISSN 2312-0541Verify ISSN ↗
Publisher: European Respiratory Society
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 37 / 165 | 77th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 6.
ERJ Open Research is Q1 in Pulmonary and Respiratory Medicine (rank 37 of 165), by CiteScore 2025.
ERJ Open Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6, which places it in quartile Q1 at the 77th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.361, quartile Q1, with an H-index of 58.
The publisher lists an article processing charge of about US$808 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ERJ Open Research is published by European Respiratory Society. Its ISSN is 2312-0541.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
ERJ Open Research has an h-index of 70 and a 2-year mean of 2.53 citations per paper (OpenAlex). Its Scopus CiteScore is 6, quartile Q1. On 2-year citations it ranks #44 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
ERJ Open Research published 548 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 63 research articles (2026), authors are most often from United Kingdom (22%), United States (7.7%) and Japan (7.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.